Effect of Salivary Phosphate-Binding Chewing Gum on Serum Phosphate in Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|123|1-2|93-101

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.123, Iss.1-2, 2013-06, pp. : 93-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

By Manghat P.   Fraser W.   Wierzbicki A.   Fogelman I.   Goldsmith D.   Hampson G.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1853-1861

Springer Publishing Company

Access to resources Recommend Favorite

Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 123, Iss. 1-2, 2013-06 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Sevelamer in a diabetologist's perspective: a phosphate‐binding resin with glucose‐lowering potential

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 116-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?

By Bielesz Bernhard  

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 194-197

Springer Publishing Company

Access to resources Recommend Favorite

Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 6, 2015-11 ,pp. : 587-593

John Wiley & Sons Inc

Access to resources Recommend Favorite